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INTRODUCTION 
Post operative adhesions form one of the most common complication following 
abdominopelvic surgeries . the  consequence of adhesion leads to lifelong 
morbidity and form major burden in surgeons operating for the second time.Few 
complications of adhesions include postoperative adhesive colic,bowel 
obstruction and female infertility 
Frequent readmissions leads to  mobility of patients.Difficulty in resurgery on 
opening the abdomen for the second time comprises an important outcome of 
adhesions.Adhesiolysis stays a temporary  mainstay treatment to remove 
adhesions as they tend to reccur following subsequent surgeries. There is need 
for thorough understanding of the formation adhesions,which is mainly due to 
reaction of the peritoneum with the intestinal loops which comes in contact with 
it,the complication of peritonitis,the pathology of bowel obstruction and the 
evolution of the adhesion barrier. 
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                                     RESEARCH PROPOSAL 
 
a) AIM AND OBJECTIVES OF THE STUDY 
Effectiveness of Seprafilm as adhesion barrier among patients undergoing  
 
elective laparotomy. 
 
 
b) INCLUSION CRITERIA 
1. All patients more than 18 years admitted in surgical wards and 
 
2.  planned for elective laparotomy. 
 
c) EXCLUSION CRITERIA 
1. Patients who are planned for/ undergoing intestinal anastomosis at the 
                time of laparotomy 
 
2. Immunocompromised patients 
d) SOURCE OF DATA:  
 
All surgical in-patients of Govt. Rajaji Hospital during the study  
 
period satisfying the inclusion criteria planned for elective/ emergency 
 
 laparotomy will be recruited for the study after obtaining valid consent. 
 
 Patients will be randomly allotted into study and control groups. 
 
e) METHOD OF COLLECTION OF DATA 
 
a. Patients under the study group will be subjected to placement of 
 
 seprafilm. 
 
b.  Contrast Enhanced Computerised Tomogram will be performed for all  
 
the patients (both study and control) during 20th post operative day to 
                                                               
evaluate the presence of intraperitoneal adhesions.                                    
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                REVIEW OF LITERATURE 
 
 
 
To understand the mechanism of action of seprafilm  in management  
 
of adhesions a thorough knowledge of the anatomy of 
 
 peritoneum,peritoneal cavity and the complications and consequences 
 
 of adhesion formation is necessary.In addition the evolution of 
 
 adhesion and various management techniques is discussed in detailed. 
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PERITONEUM 
 
EMBRYOLOGY 
The anatomy of the peritoneal cavity is such a complex and could be understood 
only by the experience of the surgeon. An understanding of the 
 alterations occurs during early part gastrointestinal 
 morphogenesis of the derivatives of the endoderm (E = epithelium) and the 
visceral mesoderm  along with the  fusion of adjoining layers of peritoneum will 
give an idea of how it presents in the adult. 
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ANATOMY 
 This thin serous membrane lines the walls of the abdominal cavity and, at 
various points, reflects onto the abdominal viscera, providing either a complete 
or a partial covering. The peritoneum lining the walls is the parietal peritoneum; 
the peritoneum covering the viscera is the visceral peritoneum.  
The continuous lining of the abdominal walls by the parietal peritoneum forms a 
sac. This sac is closed in men, but has two openings in women where the uterine 
tubes provide a passage to the outside. The closed sac in men and the semi-
closed sac in women is called the peritoneal cavity.  
Innervation  
The skin, muscles, and parietal peritoneum of the anterolateral abdominal wall 
are supplied by T7 to T12 and L1 spinal nerves. The anterior rami of these 
spinal nerves pass around the body, from posterior to anterior, in an 
inferomedial direction . As they proceed, they give off a lateral cutaneous 
branch and end as an anterior cutaneous branch.  
The intercostal nerves (T7 to T11) leave their intercostal spaces, passing deep to 
the costal cartilages, and continue onto the anterolateral abdominal wall 
between the internal oblique and transversus abdominis muscles.Reaching the 
lateral edge of the rectus sheath, they enter the rectus sheath and pass posterior    
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 to the lateral aspect of the rectus abdominis muscle. Approaching the midline, 
 an anterior cutaneous branch passes through the rectus abdominis muscle and 
the anterior wall of the rectus sheath to supply the skin.  
 
Spinal nerve T12 (the subcostal nerve) follows a similar course as the 
intercostals. Branches of L1 (the iliohypogastric nerve and ilio-inguinal 
nerve), which originate from the lumbar plexus, follow similar courses initially, 
but deviate from this pattern near their final destination.  
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                      Innervation of the anterolateral abdominal wall.  
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 Path taken by the nerves innervating the anterolateral abdominal wall. 
Along their course, nerves T7 to T12 and L1 supply branches to the 
anterolateral abdominal wall muscles and the underlying parietal peritoneum. 
All terminate by supplying skin:  
• nerves T7 to T9 supply the skin from the xiphoid process to just above 
the umbilicus;  
• T10 supplies the skin around the umbilicus;  
• T11, T12, and L1 supply the skin from just below the umbilicus to, and 
including, the pubic region ;  
• additionally, the ilio-inguinal nerve (a branch of L1) supplies the anterior 
surface of the scrotum or labia majora, and sends a small cutaneous 
branch to the thigh.  
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Arterial supply and venous drainage  
 
 Numerous blood vessels supply the anterolateral abdominal wall. Superficially:  
• the superior part of the wall is supplied by branches from the 
musculophrenic artery, a terminal branch of the internal thoracic 
artery; and  
• the inferior part of the wall is supplied by the medially placed superficial 
epigastric artery and the laterally placed superficial circumflex iliac 
artery, both branches of the femoral artery.  
At a deeper level:  
• the superior part of the wall is supplied by the superior epigastric 
artery, a terminal branch of the internal thoracic artery;  
• the lateral part of the wall is supplied by branches of the tenth and 
eleventh intercostal arteries and the subcostal artery; and  
• the inferior part of the wall is supplied by the medially placed inferior 
epigastric artery and the laterally placed deep circumflex iliac artery, 
both branches of the external iliac artery.                                                  
•                                                                                                                 
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 Arterial supply to the anterolateral abdominal wall. 
 
  
 The superior and inferior epigastric arteries run posterior to rectus abdominus 
both they enter the rectus sheath.muscle.Later  they anastomose with each other 
. 
Veins of same names follow the arteries and are contribute for venous drainage.  
Lymphatic drainage  
Lymphatic drainage of the anterolateral abdominal wall follows the basic 
principles of lymphatic drainage:  
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• superficial lymphatics above the umbilicus pass in a superior direction to 
the axillary nodes, while drainage below the umbilicus passes in an 
inferior direction to the superficial inguinal nodes;  
• deep lymphatic drainage follows the deep arteries back to parasternal 
nodes along the internal thoracic artery, lumbar nodes along 
theabdominal aorta, and external iliac nodes along the external iliacartery.  
PHYSIOLOGY OF THE PERITONEUM 
 
 Mesothelial cells are of two types- cuboidal and flattened. Cuboidal cells 
have stoma in between them, which is increased in peritonitis. Beneath the 
epithelium is a collagen layer that forms the basement membrane and still 
beneath it is a complex connective tissue composed of mast cells, fibroblasts, 
eosinophils, lymphocytes etc. Mesothelium secretes around 50- 150 ml of 
peritoneal fluid per day and its composition is similar to plasma. The peritoneal 
fluid has around 3 gm/dl which is less than that of plasma. Mesothelium and 
subdiaphragmatic lymphatics absorb fluid. Mesothelial cells also absorb solute 
by process of endocytosis. This bidirectional movement of fluids across 
peritoneal membranes has been used in peritoneal dialysis. Two primary forces 
govern the fluid flux in the cavity of peritoneum. (a) Gravity (b) Negative 
pressure that is generated below the diaphragm with respiratory movement.  
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PERITONEAL RESPONSE TO INJURY  
 
  The peritoneum initially reponds to any type of insult by producing 
a peritoneal reaction. This, microscopically can be visualised as the loss of 
mesothelial cells in that part of peritoneum. The time taken for large and small 
defects in the peritoneum are necessarily the same. It has been shown that after 
three days of peritoneal injury connective tissue cells resembling new 
mesothelium cover wound surface. At day five, new surface layer closely 
resembles adjacent normal epithelium.  On day eight mesothelium regeneration 
is complete. The exact origin of cells responsible for mesothelial regeneration 
remains unknown.  
 
 
  It is postulated, the regeneration mechanisms include 
Submesothelial cells producing new mesothelial cells. Surviving or floating 
mesothelial cells or those attached to wound edges migrating into the wound. 
Peritoneal fluid monocytes and macrophages may also be differentiating into 
mesothelial cells. Normal peritoneal wound heals without adhesion formation. 
Adhesion develops in response to factors others than simple peritoneal 
wounding.  
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  Local tissue hypoxia or ischemia appears to be the most important 
factor in adhesion formation apart from mechanical sub peritoneal surface 
injury, intraabdominal infections, and contamination of peritoneal cavity by 
foreign material. Deposition of fibrin following peritonitis is essential for 
adhesion formation. It has been shown that fibrinolytic activity is absent in 
healing wound until mesothelial cells are found. Fibrinolytic activity is minimal 
at three days in view of few mesothelial cells but complete at the end of eighth 
day, when mesothelial regeneration is complete. Therefore with intact 
mesothelial surface and adequate fibrinolysins, early fibrinous adhesions 
disappear. Formation of adhesion is both a protective response, helping to 
localize infection and an adoptive response to wound healing by carrying 
additional blood supply.  
 
PATHOPHYSIOLOGY OF PERITONITIS 
 
  Generalized or local inflammation of peritoneum is designated as 
peritonitis. Each and every case of peritonitis of whatever cause, initiates a 
sequence of responses involving the peritoneal membrane, the bowel, and the 
body fluid compartments, which then produce secondary endocrine cardiac, 
respiratory, renal, and metabolic responses.  
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PRIMARY RESPONSES IN PERITONITIS  
 
  Membrane inflammation Peritoneum reacts to injury by hyperemia 
and transudation. Edema and vascular congestion occurs in the sub peritoneal 
layer immediately external to peritoneal membrane. Absorption across inflamed 
peritoneum in early cases is increased and decreases with chronicity. 
Absorption of macromolecules appears to be more affected than small molecule 
absorption. Transudation of fluid with low protein content from the 
extracellularly interstitial compartment into abdomen is accompanied by 
diapedesis of polymorphonuclear leucocytes.  
 
 
  During the early vascular and transudative phase of engorgement, 
the peritoneum acts as a two way street such that toxins and other materials that 
may be present in the peritoneal cavity are readily absorbed, get into the blood 
and lymphatic flow and cause generalized symptoms. Transudation of 
interstitial fluid into the peritoneal cavity across the inflamed peritoneum is 
shortly followed by exudation of protein rich fluid. The fluid exudates contains 
large amounts of fibrin and other plasma proteins in concentration sufficient to 
bring about clotting later, that results in agglutination of loops of bowel, other 
viscera and the parities in the area of peritoneal inflammation. There is 
increased synthesis of lipoproteins and proteolysis. Concentration of uronic acid 
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increases reflecting the exudation of plasma proteins in the early stages of 
peritonitis and in later stages increased synthesis of glycosaminoglycans due to 
activation of fibroblasts and mesothelial cells.  
 
 
  Changes in non-collagen and collagen protein synthesis are two 
events that occur in inflamed peritoneum during peritonitis. In early peritonitis 
non- collagen protein synthesis are increased and vice versa in later stages 
owing to increased protein synthesis in total. The RNA: DNA ratio, an index of 
protein synthesizing capability of tissues, increases during the first week of 
peritonitis. Bowel response Initially, response of bowel to peritoneal irritation is 
transient hypermobility. After a short interval, motility becomes depressed and 
nearly complete adynamic ileus soon follows. Bowel distension with air and 
fluid accumulation occurs finally.  
 
 
  Hypovolaemia Peritoneum reacts to injury by hyperemia and 
transudation of fluid that almost resembles plasma from all the three 
compartments of the body viz., the extracellular, intracellular and interstitial. 
This extracelluar fluid is trapped as edema by the loose connective tissue that 
lies below the mesothelium of the organs, mesentery and parieties.This is also 
accumulated in the bowel. This shift of water along with the essential proteins 
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and electrolytes causes a temporary sequestration also called as third spacing. 
The fluid in the third space is functionally not available for the body.The 
amount of extra cellular fluid that is lost in this manner is directly proportional 
to the area of the peritoneum that is inflamed. Even massive shifts like 4-6 L in 
24 hours can occur when there is extensive peritoneal inflammation. 
 
SECONDARY RESPONSES IN PERTIONITIS  
 
Endocrine response  
 
  There is almost an immediate adrenal medullar response, with out - 
pouring of epinephrine and nor-epinephrine producing systemic 
vasoconstriction, tachycardia and sweating. There is a surge of hormones from 
the adrenal cortex during the initial few days following the peritoneal insult. 
The hypovolemia also triggers secretion of anti-diuretic hormone and 
aldosterone which increases sodium and water retention. Water retention may 
be greater than sodium retention resulting in dilutional hyponatremia.  
 
Cardiac response  
 
  The effects of peritonitis and cardiac function are a reflection, of 
both decrease in ECF volume and progress in acidosis. Volume deficit results in 
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decreased venous return and diminished cardiac output. Heart rate increases in 
an attempt to increase cardiac output, but compensation is usually incomplete. 
With ongoing acidosis, the contractile mechanism of the heart is affected and 
this further affects the cardiac output. 
 
Respiratory response  
 
  The respiratory system is involved through the diaphragm. Any 
distension of the abdomen, eg. Ileus pushes the diaphragm and this reflects as 
reduced ventilator volume and basal atelectacis. This is further aggravated by 
the restricted movement of the diaphragm and intercostal muscles due to pain. 
 
Renal response  
 
  Urine volume is diminished and renal capacity to handle an excess 
of solute is impaired. Hypovolemia reduces cardiac output and increased 
secretion of ADH aldosterone in peritonitis, all acting synergistically on the 
kidney. Renal blood flow is reduced and in turn the GFR and tubular urine flow. 
Reabsorption of water 20 and sodium is increased often in imbalance and 
potassium is wasted.  
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Metabolic response  
 
  The metabolic rate is generally increased with increased oxygen 
demand at the peripheral sites. Also, the oxygen delivering capacity of the heart 
and lungs are reduced. This poor systemic blood flow leads to a change to 
anaerobic metabolism in the peripheries like the muscle. This anaerobic 
metabolism generates lactate, which starts to accumulate. This eventually leads 
to lactic acidosis. Both ‘D’ and ‘L’ isomers of lactate are produced by bacterial 
metabolism and may be absorbed during peritonitis. Human beings can rapidly 
metabolize ‘L’ lactate, but have a relatively limited capacity to handle ‘D’ 
lactate. Protein catabolism begins early in peritonitis and progressively becomes 
severe. Plasma proteins are preferentially synthesized while muscle proteins are 
catabolized during peritonitis. 
 
PERITONITIS 
“It is the inflammtion of the peritoneum and the peritoneal cavity, either 
systemic or localised”.  
Causes for primary peritonitis include 
Bacterial 
Mycobacterial 
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Fungal 
Chlamydial 
In the absence of perforated gastrointestinal tract 
If the pathology occurs with perforation, it is termed as secondary peritonitis.  
Causes of secondary bacterial peritonitis include 
Acute peptic disease 
Appendicular pathology 
Colonic diverticulitis 
Pelvic inflammatory disease 
LOCALISED PERITONITIS  
It depends upon the area of peritoneum involved. The greater sac of the 
peritoneum is split into subphrenic, pelvis and peritoneal cavity proper. 
Peritoneal cavity is further demarcated into infracolic and supracolic 
compartments. 
Inflammation of the peritoneum causes it to lose its normal appearance and 
turns glossy giving it a fiery red appearance.  
There is fibrin formation which gives rise to formation of adhesions causing the 
intestinal loops to adhere to one another. There is pus formed in the localised 
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area due to outpouring of the inflammatory exudates and plasma proteins. 
Movements of the bowel loops is hindered thus preventing the infection to 
spread. The omentum acts as the policeman thus enveloping the area of 
involement.  
DIFFUSE PERITONITIS 
Perforation of the hollow or solid organ causes the localised infection to spread 
through a larger area.  
In such cases, early food intake increases the peristalsis further favoring the 
spread of infection. Another important factor is the virulence of the micro-
organism causing infection. In smaller children, the size of the omentum is also 
smaller, further immunodeficiency status increasing the chance of infection.  
CLINICAL FEATURES OF LOCALISED PERITONITIS 
Generalised symptoms include anorexia, nausea, generalised weakness with rise 
of temperature. There may be localised tenderness and guarding in the area 
involved. 
If the involvement is below the diaphragm, pain may radiate to the tip of the 
shoulder.  
FEATURES OF GENERALISED PERITONTIS 
Early symptoms includes generalised guarding, rise in pulse rate, decrease in 
the peristalsis of the bowel loops and a vague abdominal pain.  
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Late symptoms  
The abdomen becomes rigid with generalised tenderness. Patients present with 
sunken eyes, thready pulse, cold and clammy skin, decreased urinary output and 
low blood pressure. Paralytic ileus sets in.  
INVESTIGATIONS 
Bedside: 
ECG to rule out other causes 
Urine -  sugar/ albumin/ deposits 
Blood – Hemoglobin 
     Complete blood count 
     Serum Amylase to rule out pancreatitis 
IMAGING 
Xray chest to rule out sub-diaphragmatic gas shadow in case of perforative 
peritonitis 
Xray abdomen erect shows 
dilated gas filled bowel loops 
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presence of gas in biliary tree 
If patient cannot be made erect, lateral decubitus view may be taken 
Contrast Enhaced CT 
To rule out the cause of peritonitis 
MANAGEMENT 
Fluid and electrolytes: Usually these patients present with low blood pressure 
due to hypovolemia and third space collection. So correction of fluid and 
plasma volume initiates the first line of management. 
Correction of electrolyte abnormalities if present 
Catheterisation of bladder – reflects the central perfusion and guides in fluid 
management 
Nasogastric tube insertion -  to decompress the bowel, to aspirate its contents till 
the bowel begins to function normally 
In cases of septic shock, central venous pressure monitoring may be useful 
Antibiotic therapy -  broad spectrum antibiotics giving cover to both aerobic and 
anaerobic organisms should be administered to prevent the release of 
endotoxins 
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Specific treatment 
Early surgical intervention is preferred over surgical management. Specific 
consideration should be given to patients with co-morbidities. Surgery is 
directed in removal of the primary pathology providing an adequate peritoneal 
lavage followed by drainage.  
Thorough laparotomy should be done and thorough wash with copious normal 
saline seems to be effective.  
PROGNOSIS 
About 12% mortality has been reported worldwide. It is mainly influenced by 
the age, time of presentation and severity of disease process 
ABDOMINAL ABCESS 
Abdominal abscesses are formed in areas of localized peritonitis in which the 
infection is walled off by a barrier such as omentum and parietal or visceral 
peritoneum. Infectious organisms that are capable of inciting a localized 
peritoneal response include various gram-negative enteric bacteria, 
Enterococcus, Bacteroides, and yeast. Once the peritoneum is activated 
secondary to both a local and systemic cytokine response, there are changes in 
blood flow, enhancement of bacterial phagocytosis, and fibrin deposition to trap 
bacteria. The bacterial sequestration by fibrin slows the systemic spread of 
bacteria thereby reducing the risk of overwhelming bacteremia. However, the 
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deposition of fibrin may also protect the bacteria from usual host defenses, thus 
establishing a persistent infection that can result in abscess formation.1 
Abdominal abscesses have been classically divided into three categories: 
intraperitoneal (anatomically described above), retroperitoneal, and visceral. 
Intraperitoneal abscesses generally develop one of two ways. The first is a result 
of diffuse peritonitis in which loculations of purulent material form in the most 
dependent areas. The second mode of formation is due to a contiguous disease 
process or injury in which the host defenses adequately prevented diffuse 
peritonitis and walled off the process.2Retroperitoneal abscesses form in the 
potential space between the peritoneum and the transversalis fascia lining the 
posterior aspect of the abdominal cavity. Visceral abscesses develop within the 
confines of one of the abdominal viscera such as the liver, pancreas, or 
gallbladder. These abscesses typically form as a result of hematogenous or 
lymphatic seeding from various sites, or in the case of the gallbladder, 
infectious cholecystitis. 
Intra-abdominal abscesses are best treated quickly and effectively, as the 
mortality of patients with intra-abdominal abscesses ranges from 10–20%. 
Factors influencing outcome include organ failure, lesser sac abscesses, positive 
blood cultures, recurrent and/or persistent abscesses, multiple abscesses, age 
greater than 50 years, and subhepatic abscesses. Data show that the deaths from 
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abdominal abscess are for the most part the consequence of ineffective or 
untimely drainage.3 
Clinical Presentation 
In surgical practice, extravisceral abscesses form following failed anastomoses, 
infection of intraperitoneal fluid collections following abdominal surgery, 
contained leakage from a spontaneous visceral perforation, or residual 
loculations following diffuse peritonitis. High spiking fevers, chills, abdominal 
pain, anorexia, and delay of return of bowel function in the postoperative patient 
are typical presenting signs and symptoms of intraperitoneal abscess. 
Subphrenic abscesses can present with vague upper quadrant abdominal pain, 
referred shoulder pain, and occasionally hiccoughs. Typically, paracolic and 
interloop abscesses present with localized tenderness and may manifest as a 
palpable mass on abdominal examination. Abscesses may also cause local 
irritation of the urinary bladder causing frequency, or of the rectum resulting in 
diarrhea and tenesmus. 
Diagnosis 
Abdominal plain films can be helpful in identifying air-fluid levels in the 
upright or decubitus positions, extraluminal gas, or a soft tissue mass displacing 
the bowel. Chest radiographs may help to differentiate subphrenic from pleural 
fluid collections. Plain radiography may suggest the presence of an abscess, but 
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other imaging modalities have essentially replaced plain films in the evaluation 
of intra-abdominal abscesses 
The initial use of ultrasound in the diagnosis of intra-abdominal fluid 
collections was found to have several advantages and disadvantages. The 
accuracy of ultrasound in the diagnosis of intra-abdominal abscesses was found 
to be 97% with a sensitivity of 93% and a specificity of 99%.4 Ultrasonography 
allows for a rapid and complete examination of the abdomen, even in extremely 
ill patients. When one considers the cost of ultrasound, it remains an important 
tool. In addition, it usually does not require transportation of a critically ill 
patient, as it can be performed at the bedside, an important consideration. 
The utility of ultrasound, however, is dependent on the skills and experience of 
the operator. These are several limitations to the utility of ultrasound. First, in 
regions other than the pelvis, the right upper quadrant, and the left upper 
quadrant when the spleen is present, optimal imaging is difficult to achieve5 
(Fig 7–2). Second, in patients with an ileus, a situation that is not uncommon 
with an intra-abdominal abscess, imaging is distorted by bowel gas. Other 
common issues in surgical patients that can impede ultrasound include staples, 
wound dressings, and stomas. Next, it was found that the ultrasonic 
characteristics of abscesses and hematomas overlapped. Furthermore, the nature 
of the fluid as determined by ultrasound could only occasionally help determine 
the composition of the fluid collection. 
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BOWEL OBSTRUCTION 
Praxagoras cerca was the first surgeonto perform surgery for bowel obstruction 
in 350B.C. 
Few causes of obstruction include hernia,neoplasm or reasons related to 
biochemical abnormalities,.Recognising the underlying etiology is important 
thereby necessiciting early intervention to reduce ischemia and necrosis.this 
reduces long term morbidity and mortality. 
Definition 
Obstruction occurs when there is a stoppage or decrease in normal propulsion of 
the bowel.There may be involvement of small or large bowel or even 
both.Causes may be mechanical or due to improper morbidity as in the case of 
functional obstruction.It can also be classified to etiology,the time at which it 
presents,the duration and the extent. 
 
 
Mechanical Bowel Obstruction 
Intestinal obstruction due to block in the bowel either intrinsic or extrinsic to the 
bowel.In partial obstruction the lumen of the intestine is narrowed but still allow 
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passage of its content aborally.In complete obstruction there  total obstruction 
and no movement of bowel contents. 
There is increased risk of strangulation in patients presenting with complete 
obstruction.It is further classified into three types 
1.Simple obstruction-there is no vascular compromise.the bowel can be 
decompressed proximally. 
2.Closed loop obstruction-occurs when the bowel segment on either side is 
obstructed thus causing an icrease in intraluminal pressure.There is increase in 
the accumulation of fluid in the bowel involved.There is an increased 
predisposition of vascular compromise for these patients.This type of vascular 
compromise may be reversible or irreversible. 
 
Lesions Extrinsic to the Intestinal Wall Lesions Intrinsic to the Intestinal Wall  
ADHESIONS CONGENITAL  
Postoperative Intestinal atresia  
Congenital Meckel's diverticulum  
Postinflammatory Duplications/cysts  
HERNIA INFLAMMATORY  
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External abdominal wall (congenital or acquired) Crohn's disease  
Internal Eosinophilic granuloma  
Incisional INFECTIONS  
CONGENITAL Tuberculosis  
Annular pancreas Actinomycosis 
Malrotation Complicated diverticulitis  
Omphalomesenteric duct remnant NEOPLASTIC  
NEOPLASTIC Primary neoplasms  
Carcinomatosis Metastatic neoplasms  
Extraintestinal neoplasm Appendicitis  
INFLAMMATORY MISCELLANEOUS  
Intra-abdominal abscess Intussusception  
"Starch" peritonitis Endometriosis  
MISCELLANEOUS Radiation enteropathy/stricture  
Volvulus Intramural hematoma  
Gossypiboma Ischemic stricture  
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Superior mesenteric artery syndrome INTRALUMINAL/OBTURATOR 
OBSTRUCTION  
  Gallstone  
Enterolith 
Phytobezoar 
  Parasite infestation  
  Swallowed foreign body 
 
Functional Bowel Obstruction 
 
When the obstruction is secondary to factors that cause either paralysis or 
dysmotility of intestinal peristalsis that prevents coordinated aboral transit of 
luminal contents, the obstruction is called a functional or pseudo-obstruction . 
With functional obstruction, no physical site of mechanical obstruction is 
present. Postoperative ileus is the most common form of functional bowel 
obstruction, since it is present to some extent after most intra-abdominal 
operative procedures. A transient ileus may also develop in response to various 
types of extra-abdominal medical and surgical conditions. In addition to these 
forms of ileus that occur in response to local or systemic stimuli, there is a 
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group of rare, progressive, chronic, idiopathic gastrointestinal pseudo-
obstructions that are related either to hereditary or acquired visceral myopathies, 
visceral neuropathies, or a poorly understood disruption of myoneural 
coordination of organized contractile activity. 
 Functional Bowel Obstruction, Ileus, and Pseudo-Obstruction 
 
 
 
Intra-Abdominal Causes Extra-Abdominal Causes  
INTRAPERITONEAL PROBLEMS THORACIC PROBLEMS  
Peritonitis Myocardial infarction  
Intra-abdominal abscess Congestive heart failure  
Postoperative (physiologic) Pneumonia  
Chemical: Thoracic trauma  
  Gastric juice METABOLIC ABNORMALITIES  
  Bile Electrolyte imbalance  
  Blood Sepsis  
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Autoimmune: Lead poisoning  
Serositis Porphyria  
VasculitisHyperglycemia/ketoacidosis  
Intestinal ischemia: Hypothyroidism  
  Arterial or venous Hypoparathyroidism 
  Sickle-cell disease Uremia 
RETROPERITONEAL PROBLEMS MEDICINES  
Urolithiasis Opiates  
Pyelonephritis Anticholinergics 
Metastasis Alpha-adrenergic agonists   
Pancreatitis Antihistamines   
Retroperitoneal trauma/hematoma Catecholamines 
  MISCELLANEOUS  
  Spinal cord injury  
  Pelvic fracture  
  Head trauma  
  Chemotherapy  
 34 
 
  Radiation therapy  
  Renal transplantation  
 
Postoperative ileus represents the most common cause of delayed hospital 
discharge after abdominal operations. Patients operated on for radiation 
enteropathy, chronic obstruction, or severe peritonitis are susceptible to a more 
prolonged postoperative ileus; with radiation enteropathy, the ileus is probably 
related to radiation-induced damage to neuromuscular coordination in the 
irradiated segments. Different anatomic segments of the gastrointestinal tract 
also recover at different rates after manipulation and trauma. The small bowel 
generally recovers effective motor function within several hours after the 
operation; indeed, contractile activity in the small intestine remains present even 
during a celiotomy. In contrast, the stomach may take 24–48 hours to regain 
normal motor activity, while the colon recovers in about 3–5 days 
postoperatively; neither of these organs show spontaneous contractions or 
respond to manual compression with visible contraction (as does the small 
intestine) during a celiotomy.1 It is important to differentiate postoperative ileus 
both from an early postoperative mechanical bowel obstruction. This distinction 
may be important, because paralytic or generalized ileus usually is secondary to 
or caused by different pathophysiologic mechanisms. 
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Early Postoperative (Mechanical)Bowel Obstruction 
 
Bowel obstruction occurring within the first 6 weeks postoperatively is 
classified as an early postoperative bowel obstruction. This type of obstruction 
can be considered a distinct clinical entity with a unique pathophysiology that 
should be differentiated from classic mechanical bowel obstruction and from 
postoperative ileus. Acute adhesions are the responsible cause in over 90% of 
the episodes of early postoperative obstruction that require surgical 
management. Other causes include internal herniation, intra-abdominal abscess, 
intramural intestinal hematoma, and anastomotic edema or leak. The special 
circumstance of the patient who has recently undergone an operation may make 
early postoperative bowel obstruction quite difficult or impossible to 
differentiate from postoperative ileus. Nausea, vomiting, abdominal distention, 
and obstipation are themselves relatively common findings in the early 
postoperative period. Initially, the symptoms of early postoperative mechanical 
obstruction tend to be vague, and patients are often labeled as having 
postoperative ileus. The abdominal exam is seldom helpful because of pain 
secondary to the recent incision or the use of narcotic analgesics masking the 
underlying pain picture. Imaging studies may also be difficult to interpret, since 
early postoperative bowel obstruction and ileus can manifest with similar 
findings on plain abdominal radiographs.CT is an important tool in 
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diagnosingto differentiate and decide the line of managementto those benefit 
from conservative line of management over surgical management.this can done 
by identifying the site of obstruction or the presence of dilated proximal bowel 
with acollapsed distal bowel 
Epidemiology 
 
 Both the etiology and frequency of bowel obstruction changed dramatically 
during the 1900s. During the first third of the 20th century, the most common 
cause of bowel obstruction was incarcerated hernia. The widespread growth of 
therapeutic intra-abdominal surgery in the second half of the 20th century led to 
an increase in the frequency of postoperative adhesive obstruction and a 
decrease in the relative frequency of obstruction secondary to hernias. This 
decrease in the frequency of obstruction secondary to incarcerated hernias is 
due to the early diagnosis and surgical management of most abdominal wall 
hernias, especially in industrialized countries. Bowel obstruction in Third World 
nations manifests as with different clinical picture resembling that found in the 
early 20th century in Western societies. In the future, wider application of 
minimal access laparoscopic approaches may decrease the frequency of bowel 
obstruction secondary to postoperative adhesions,4 but this putative trend has 
yet to be confirmed. 
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There is a slightly higher frequency of bowel obstruction in women due to the 
fact that obstetric, gynecologic, and other pelvic surgical procedures are 
important etiologies for the development of postoperative adhesions. 
 
Although possible, abdominal wall hernias rarely cause a true, isolated large 
bowel obstruction, while adhesions, unlike for small bowel obstruction, 
represent an exceedingly uncommon cause of a large bowel obstruction. In 
contrast, small bowel obstruction in most advanced Western societies is caused 
most commonly by adhesions, neoplasms, or abdominal wall hernias. 
 
The costs incurred and the resources expended in the treatment of intestinal 
obstruction represent a significant burden on the national health care system for 
any country.  Indeed, it has been estimated that 1% of all hospitalizations, 3% of 
emergency surgical admissions to general hospitals, and 4% of major 
celiotomies (about 250,000) are secondary to bowel obstruction or procedures 
requiring adhesiolysis.5 Another study showed that between 12% and 17% of 
patients who have undergone a total colectomy are admitted for small bowel 
obstruction within 2 years of their index operation, while approximately 3% will 
require an operation to treat an established small bowel obstruction. 
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Pathophysiology 
 
Luminal obstruction results in prominent alterations of the normal intestinal 
physiology. Despite the many changes noted, the pathophysiology of bowel 
obstruction remains incompletely understood. Bowel distension, decreased 
absorption, intraluminal hypersecretion, and alterations in motility are found 
universally, yet the mechanisms responsible for these pathophysiologic 
derangements are not clear. Neural and hormonal control mechanisms, 
endogenous bacterial flora, and the innate immunity of the gut are also 
disrupted. 
 
The older classic literature addressing the pathophysiology of bowel obstruction 
maintains that a decrease in blood flow is responsible for most of the 
pathophysiologic changes. More recent experimental work, however, suggests 
that many of the pathophysiologic changes that occur with bowel obstruction 
are in part related to the increases in blood flow seen during the early phases of 
bowel obstruction in association with an intramural inflammatory reaction. 
Indeed, strong evidence suggests that this inflammatory reaction plays a key 
role in the pathophysiology of the intestinal response to obstruction. Recent data 
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show that mucosal production of reactive oxygen species may be one important 
mediator of some changes seen in simple mechanical bowel obstruction.6 
 
Distention, Absorption, and Secretion 
 
Bowel distension represents a characteristic, fundamental, and constant 
physiologic derangement present in mechanical bowel obstruction. The 
mechanism underlying the intestinal distention has also not been elucidated 
fully. Most of the gas distending the small bowel in the early phases of 
obstruction accumulates from swallowed air. As would be expected, 
intraluminal gas consists of approximately 75% nitrogen in the obstructed 
bowel. Other sources of gas arise from the fermentation of sugars, production of 
carbon dioxide by interaction of gastric acid and bicarbonates in pancreatic and 
biliary secretions, and diffusion of oxygen and carbon dioxide from the blood. 
Dilatation and inflammation of the bowel wall may cause activated neutrophils 
and macrophages to accumulate within the muscular layer of the bowel wall, 
inhibiting or causing damage to secretory and motor processes by release of 
reactive proteolytic enzymes, cytokines, and other locally active substances. 
This inflammatory response leads to an increase in the local release of nitric 
oxide, itself a potent inhibitor of smooth-muscle tone, further aggravating the 
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intestinal dilatation and inhibition of contractile activity. The amount and 
activity of nitric oxide synthase, the enzyme that synthesizes nitric oxide, 
correlates with the severity of intestinal dilatation. Experimental data also 
support the presence of a close relationship between distension and the 
intramural production of reactive oxygen metabolites which modulate not only 
gut motility but also gut permeability. 
 
During the first 12 hours of an obstruction of the small bowel, water and 
electrolytes accumulate within the lumen secondary to a decrease in net 
absorption. By 24 hours, intraluminal water and electrolytes accumulate more 
rapidly secondary to a further decrease in absorptive flux and a concomitant 
increase in net intestinal secretion (secretory flux) apparently secondary to 
mucosal injury and increased permeability; intraluminal leakage of plasma, 
electrolytes, and extracellular fluid occurs. Whether associated neural or 
systemic humoral/hormonal mechanisms also aggravate this upregulation of 
unidirectional secretory flux remains likely but poorly investigated. 
 
Intraluminal bacteria-derived toxins, bile acids, prostaglandins, vasoactive 
intestinal polypeptide, and mucosa-derived oxygen free radicals accumulate and 
all exacerbate this fluid secretion into the lumen of the obstructed bowel. The 
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decrease in the absorptive capacity and increase in secretion leads to important 
fluid losses which can lead to dehydration if not recognized and treated. 
Although the intestinal wall distal to the obstruction maintains relatively normal 
function, the inability of the luminal content to reach the unobstructed small 
bowel and colonic absorptive surface is an important component of the overall 
dehydration. 
 
Intestinal Motility 
 
In the early phase of bowel obstruction, intestinal contractile activity increases 
in an attempt to propel intraluminal contents past the obstruction. Later in the 
course of the bowel obstruction, the contractile activity diminishes, probably 
secondary to intestinal wall hypoxia and the exaggerated intramural 
inflammation; however, the exact mechanisms have not been adequately 
described. Some investigators  have suggested that the alterations in intestinal 
motility are secondary to a disruption of the normal autonomic parasympathetic 
(vagal) and sympathetic splanchnic innervation. 
The splanchnic innervation has been the focus of extensive research, and 
especially so in the pathogenesis of ileus. Chemical sympathectomy has been 
successful in ameliorating the ileus in several experimental models of ileus. 
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Other approaches have focused on blocking the neural inhibitory mechanisms 
affecting enteric neuromuscular coordination. Still other experimental 
approaches have been designed to prevent or inhibit the inflammatory response 
that accompanies the "physiologic" (postoperative) response to celiotomy or the 
abnormal inflammatory response accompanying generalized ileus. 
 
Circulatory Changes 
 
Ischemia of the bowel wall can occur by several different mechanisms. 
Extrinsic compression of the mesenteric arcades by adhesions, fibrosis, a mass, 
or a hernia defect; an axial twist of the mesentery; local chronic serosal-based 
pressure on a segment of the bowel wall (e.g., a fibrous band); or progressive 
distention in the presence of a closed-loop bowel obstruction can all cause 
vascular compromise or strangulation. The worry about vascular compromise is 
more acute in large bowel obstruction, because about 40% of people have a 
competent ileocecal valve, which functionally leads to a form of closed-loop 
obstruction. 
 
Progressive distention of the bowel lumen with a concomitant increase in 
intraluminal pressure results in increased transmural pressure on capillary blood 
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flow within the wall of the bowel. For simple (non–closed loop) obstruction, 
this scenario rarely occurs, because the obstructed distended bowel can 
decompress proximally. In contrast, the possibility of intestinal wall ischemia is 
a very real concern in large bowel obstruction, when the ileocecal valve is 
competent and the distended colon cannot decompress retrograde into the small 
bowel. The resultant bowel wall ischemia may eventually lead to compromise 
of blood flow by exceeding venous pressure. This scenario is most common in 
the ascending colon where the luminal diameter is the greatest and (by Laplace's 
law) the wall tension (and ischemia) is also the greatest. This potential 
phenomenon actually makes large bowel obstruction more of a surgical 
emergency than small bowel obstruction. This type of bowel wall ischemia 
leads to further disruption of intestinal absorption with a relative increase in net 
secretion, an unregulated increase in mucosal permeability, and intramural 
production of reactive oxygen species by activated resident and recruited 
leukocytes, causing peroxidation of the lipid components of the cellular 
membrane, release of cytokines and other inflammatory mediators, and 
systemic toxicity. With strangulation, there can also be blood loss into the 
infarcted bowel, which together with the preexistent fluid loss leads to further 
hemodynamic instability, which exacerbates the already compromised blood 
flow of the intestinal wall. 
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Microbiology and Bacterial Translocation 
 
The upper small intestine contains resident and transient flora consisting mainly 
of gram-positive facultative organisms in small concentrations, usually <106 
colonies/mL. More distally, the bacterial count increases in concentration to 
about 108 colonies/mL in the distal ileum, and the flora changes to primarily 
coliforms and anaerobic organisms. However, in the presence of obstruction, a 
rapid proliferation of bacterial organisms occurs proximal to the point of 
obstruction, consisting predominantly of fecal-type organisms. These fecalflora 
proliferate in direct proportion to duration of obstruction, reaching a plateau of 
109–1010 colonies/mL after 12–48 hours of an established obstruction. The 
bowel distal to the obstruction tends to maintain its usual bacterial flora until a 
generalized ileus sets in, and then even here, bacterial proliferation occurs. 
Bacterial toxins have an important role in the mucosal response to bowel 
obstruction. Experiments in germ-free dogs with a mechanical bowel 
obstruction have shown that intraluminal accumulation of fluid and net 
electrolytes does not occur and net absorption continues. 
 
In persistent bowel obstruction, experiments in rodents showed that bacterial 
translocation can occur secondary to impairment of the barrier function of the 
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intestinal mucosa. This disruption of the mucosal barrier begins to occur early 
after the onset of bowel obstruction. The endoplasmic reticulum dilates as early 
as 4 hours after onset of bowel obstruction. Mitochondrial edema, focal 
epithelial necrosis, intracellular swelling, and degenerative lesions in the 
nucleus of epithelial cells (apoptosis) have been demonstrated after 6–12 hours 
of obstruction in these experimental models.8 Reduction of perfusion of the 
intestinal wall further compromises the mucosal defenses. When the mechanical 
integrity of the mucosa is lost, luminal bacteria invade the submucosa and enter 
the systemic circulation via the portal venous and lymphatic systems. Several 
bacterial substances can be retrieved from peritoneal fluid and lymphatic 
channels even in the absence of perforation. In rodents, bacteria can be cultured 
from the spleen, liver, and mesenteric lymph nodes, indicative of a marked 
increase in bacterial translocation. 
 
The very elegant studies demonstrating bacterial translocation in the rodent led 
to erroneous assumptions about similar bacterial "translocation" in humans. 
However, documentation of true bacterial translocation in humans is notably 
lacking, and true bacterial translocation in man seems unlikely. Several studies 
that tried to document the presence of bacteria in intra-abdominal lymph nodes, 
spleen, liver, and even lymphatics have been unsuccessful in reproducing the 
results noted in the animal models. In contrast, more recent work has shown that 
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lipopolysaccharide and other inflammatory mediators, but not bacteria, can be 
recovered from the mesenteric lymphatics. The eventual drainage of these 
vasoactive substances into the systemic circulation may lead both to the 
systemic manifestations of sepsis and further disruption of the mucosal barrier 
function. 
 
The importance of this change in the intraluminal bacteriology in simple 
intestinal obstruction is that the risk of infective complications is increased 
markedly, and especially so if an intestinal resection is required or if an 
inadvertent enterotomy is made with intraperitoneal spillage of "obstructed" 
enteric contents. In contrast, with strangulation obstruction, it is clear that a 
myriad of local and systemic alterations, such as systemic entry of bacterial 
products, activation of immunocompetent cells, release of cytokines, and 
increased formation of reactive oxygen intermediates, can promote the systemic 
inflammatory response syndrome and can progress to multiple organ 
dysfunction. 
 
 
 
 
 47 
 
Etiology 
 
Adhesions 
 
Adhesions may be defined as abnormal connective tissue attachments between 
tissue surfaces. Adhesions can be congenital or acquired (postinflammatory and 
postoperative). Congenital or inflammatory adhesions are infrequent causes of 
bowel obstruction, except in selected circumstances such as malrotation or 
persistent urachus, among others. Postoperative adhesions are the leading cause 
of small bowel obstruction in Western societies and are responsible for 40–80% 
of bowel obstructions seen in most hospital surgical services. This wide 
variation in incidence of adhesive obstruction varies with different referral 
patterns, community settings, racial cultures, and countries. 
 
Some element of adhesion formation is nearly universal after celiotomy and 
starts as early as the first postoperative hours. Much of the pathogenesis of 
adhesion formation remains unknown. Experts agree that it is a surface event 
associated with some form of peritoneal injury. The inciting trauma triggers an 
inflammatory response leading to activation of the complement and coagulation 
cascades, along with exudation of fibrinogen rich fluid; the full establishment of 
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this response is present 5–7 days after the peritoneal trauma of a celiotomy.10 
Recent findings have identified the presence of sensory nerve fibers in human 
peritoneal adhesions, suggesting that these structures may even be capable of 
conducting pain. 
 
Peritoneal healing appears to differ from the response in skin, where re-
epithelialization occurs from the periphery inwards. In the peritoneum, surgical 
or traumatic defects are re-peritonealized by implantation of mesothelial cells in 
multiple areas of the defect. This mesothelialization takes place quite rapidly 
and is often complete by 2–5 days after the injury, depending on local 
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conditions. 
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Normal peritoneal healing is a complex, interrelated, programmed inflammatory 
process. The initial response involves the influx of polymorphonuclear 
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leukocytes and lymphocytes within fibrin strands. During the next 24–36 hours, 
numerous macrophages have infiltrated the wounded area, recruited by various 
chemokines. By 48 hours, a fibrin scaffold overlying the defect has been 
established, covered by macrophages and a few mesothelial cells which then 
coalesce to fully mesothelialize the defect over the next 2–4 days. The 
underlying fibrin scaffold is populated by fibroblasts and other mesenchymal 
cells that begin to lay down a basement membrane, so that by 8–10 days, a 
single layer of mesothelial cells resting on a continuous basement membrane is 
established; the underlying reactive matrix and inflammatory cells then regress. 
 
Adhesion formation can be considered a pathologic process as opposed to the 
above described process. It appears that adhesions form in response to the initial 
fibrin gel matrix combined with the local microenvironment. This fibrin gel 
matrix consists of numerous types of cells, including the initial leukocytes, but 
also other humorally active cells such as platelets, mast cells, and erythrocytes, 
as well as surgical debris and possibly bacteria. The resultant spectrum between 
mesothelial healing versus adhesion formation varies among individuals and is 
dependent on many other conditions, such as inflammation, infection, 
devitalized tissue, and foreign bodies as well. 
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If the fibrin gel allows apposition of adjacent surfaces, a band or bridge may 
form (i.e., an adhesion). This process of adhesion formation also is a dynamic 
process, consisting predominantly of macrophages early on, but by 2–4 days, 
larger strands of fibrin and fibroblasts begin to appear. By 5 days, distinct 
bundles of collagen are apparent, and fibroblasts begin to form a syncytium 
within the matrix. These cells thereafter predominate, and eventually the fibrin 
matrix and cellular elements are replaced by a vascularized, granulation-type 
tissue containing macrophages, fibroblasts, giant cells, and a rich vascular 
supply. Eventually the surface of the adhesions are covered by a mesothelial 
layer, but only after formation of the underlying fibrous scar leading to surface 
opposition and transperitoneal bands. 
 
The type of surgical procedure is also an important factor in determining the 
risk of future adhesive bowel obstruction. The operations most frequently 
associated with adhesive bowel obstruction are those involving the structures in 
the inframesocolic compartment, and especially the pelvic region, such as 
colonic, rectal, and gynecologic procedures. Adhesive bowel obstruction may 
occur at any time postoperatively after a celiotomy, with reports ranging as 
early as within the first postoperative month to more than 8 decades after the 
index operation. A study by Menzies and Ellis13 found that about 20% of 
adhesive bowel obstructions occur within 30 days after the initial celiotomy, 
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about 20% occur between 1 and 12 months postoperatively, another 20% tend 
to occur between 1 and 5 years postoperatively, and the remainder (~30%) 
occur after 5 years. A Norwegian study of patients requiring an operation for 
adhesive bowel obstruction found that most episodes of recurrent bowel 
obstruction occurred within 5 years after the previous episode, but the risk was 
still present more than 20 years after a prior episode, reaching an incidence as 
great as 29% at 25 years.14 Therefore, a common predisposition to adhesive 
obstruction is the presence of a prior episode of adhesive obstruction. Numerous 
attempts to decrease or prevent the development of postoperative adhesions 
have been reported and will be discussed below.Adhesion Prevention 
 
Over the last 100 years, multiple approaches have been employed in an attempt 
to prevent the formation of unwanted postoperative adhesions. These include, 
among others, cow cecum, shark peritoneum, and fish bladder, and multiple 
fluids, mechanical barriers, and gels. The concept of separating injured surfaces 
to prevent adhesions is a very attractive one. The formation of fibrin bridges 
(and thus adhesions) may be preventable by separating injured surfaces in the 
postoperative interval during the critical period of healing and 
mesothelialization by application of an absorbable "biofilm." Estimates of the 
minimum amount of time necessary for an impermeable or semipermeable 
barrier to prevent adhesion formation appears to be about 36 hours. Some 
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authors have placed a Silastic® sheet between two injured peritoneal surfaces; 
when left in place for 36 hours, no adhesions formed thereafter. Others have 
postulated that separating the surfaces at risk for the first 5–7 days until full 
mesothelialization occurs would seem to be most effective. However, the barrier 
should not incite its own inflammatory response and should not reduce 
fibrinolytic activity or suppress access to oxygen. The ideal product, therefore, 
should be bioabsorbable (preferably via a process such as hydrolysis), last only 
about 5–7 days, be easy to apply, and be interposed between all injured 
surfaces. Similarly, it cannot itself cause a foreign body reaction or impair either 
the normal wound healing process of an intestinal anastomosis or the fascial 
closure or mesothelial cell migration and proliferation. These ideal requirements 
are quite lofty. The most effective method to date has been the application of a 
sheet of bioresorbable, hyaluronate membrane; this approach has been shown to 
decrease the formation of adhesions at the site of application.42,43 Although it 
is unknown, it is unlikely that this method will result in decreased adhesion 
formation at sites other than at the site of application. It is also important to 
remember that these studies have shown hyaluronate barriers to decrease the 
rate of postoperative adhesion formation, not postoperative bowel obstructions. 
Data from the Adhesion Study Group suggest hyaluronate barriers may 
modestly decrease the relative risk of developing an adhesive bowel obstruction 
among patients undergoing resection (personal communication). 
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Initial concerns were raised over the safety of hyaluronate barriers. Interest 
centered on worry about an increased risk of postoperative abscess, pulmonary 
embolism, fistula formation, peritonitis, and anastomotic leak. Concerns over 
the safety of hyaluronate membranes stemmed from initial studies on the impact 
of hyaluronate membranes on adhesion formation, as well as complications 
related to a gel preparation of hyaluronate cross-linked with iron, which has 
been withdrawn from the market. A subsequent prospective, randomized, 
controlled trial showed that hyaluronate barriers did not increase the risk of 
intra-abdominal abscess or pulmonary embolism. However, in a post-hoc 
subgroup analysis of 289 patients in whom the hyaluronate membrane was 
wrapped around a fresh anastomosis, the rates of leak, fistula formation, 
peritonitis, abscess, and sepsis were increased. This observation suggests that 
"adhesions" or at least the access of the intraperitoneal microenvironment play 
an important role in the normal healing of bowel anastomoses. Indeed, 
peritoneal fluid contains multiple growth factors that may promote certain 
aspects of wound healing. Therefore, future attempts to prevent adhesions using 
materials such as more fluid-type gels and liquids that can more completely 
interpose between surfaces at risk need to bear in mind that not all adhesions are 
bad. For instance, use of sea snake venom, a potent protease with intense 
fibrinolytic activity, effectively prevented all adhesions, but in doing so also 
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prevented healing of the surgical wound and any other wounds as well. Also, 
any surface coating agent that prevents contact of the peritoneal fluid and even 
the omentum, both of which contain certain growth factors that promote sealing 
and healing of anastomoses or areas of peritoneal trauma, may actually be 
detrimental to outcome. Based on these studies and assumptions, the use of 
hyaluronate membranes in elective abdominal surgery decreases the amount of 
postoperative adhesions and may decrease the rate of mechanical obstruction, 
although their routine use may not be warranted and awaits further study. 
 
Other materials are being developed that someday may move to the forefront of 
adhesion prevention. These include gel and liquid preparations such as 
hyaluronic acid and carboxymethylcellulose, hydrogel, fibrin sealant, and 
protein polymers. Other adhesion barriers include oxidized regenerated 
cellulose (ORC). ORC has been well studied and does help prevent adhesion 
formation, but its use requires a blood-free field which at times is not practical 
to achieve. The use of ORC, like hyaluronate membranes, has not been shown 
to decrease the incidence of adhesive small bowel obstruction. 
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ADHESION BARRIERS 
The are classified into two categories 
1.free floating variant 
2.mechanical barriers 
FREE FLOATING 
This includes 
CRYSTALLOID SOLUTIONS 
1.LACTATED RINGER SOLUTION-where used with the mechanism that it 
 could prevent tissue apposition.about 500 ml of ringer lactate was instilled but  
this showed no improvement in preventing adhesions. 
Certain cases showed increase as it is reabsorbed in the peritoneal cavity as it is 
reabsorbed  in the peritoneal cavity within 12 hours as the duration of adhesion 
formation is approximately 5-7 days 
2.DEXTRAN-32% solution of Dextran70 was used in the past as it prevented 
adhesion in areas were it was pooled. 
Due to high complication rate such as ascites,edema and pleural effusion it is no 
longer used in practise. 
3.HYALURONIC SOLUTION-INTERGEL adhesion solution 
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The use of this is that hyaluronic acid is normally present as a component of 
peritoneal fluid which helps in tissue lubrication and maintain structural 
integrity. 
The disadvantage in that it has a low viscosity and it gets absorbed easily.A 
change was made with addition of ferric ion thus it increasesthe viscosity and 
the duration in peritoneal cavity.There was a significant decrease in adhesion 
not only in site of application but through the entire peritoneal cavity.There is 
possibilityof peritonitis, ileus and anastamotic leaks.so it was voluntarily 
removed from market. 
ACP GEL 
 Is a form cross link hyaluonicic acid. This increases the viscosity. Minimal 
complication of intra abdominal bleeding is the disadvantage. This product is 
widely utilised in Europe.   
SPRAY GEL 
It consist of hydrophilic  polyethene glycol base barrier. It is formed by 
spraying its liquid precursors as double form into specific sites.the precursors 
then polymerises to form a gel that covers the tiisue. After around 5 days,this 
component is reabsorbed under renal clearance.it was found to decrease 
adhesions rat caecum and uterine horn models.in humans, its has its advantage 
in operative hysteroscopy. 
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ADEPT 
A new barrier which has got its FDA approval mainly used in laprascopy.its 
component contains 4%isodextrose solution.it was found to be  useful in  a lot 
of studies. Very few developed sepsis and  anastamotic leak problem  
Ø An experimental solution which is under study is an INTRA 
PERITONEAL PHOSPHOLIPID  which found to decrease 
adhesion incidence  
MECHANICAL BARRIER 
Ø Lot of membranes have been developed for preventing adhesions 
INTERCEED: 
It is composed of oxidised segmental cellulose and its absorbable.it is very 
efficient and safe in preventing adhesions. Due to its poly anionic nature it 
replaces the macrophage scavenger receptor, this causes decreases in the 
secretion of  components of  matrix mediators of inflammation and certain 
growth factor responsible  for cellular function. It prevents the growth and 
multiplication of bacteria and shows no reaction.it forms a gel like material 
once its placed inside and gets metabolised within 4 days. Main use of intercede 
is to prevent pelvic adhesion formation. 
DISADVANTAGE 
Ø As much as the tissue under the trauma must be covered  
Ø Increase fluid in the peritoneum with bleed reduces its efficacy 
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GORETEX 
Ø Contains polytetrafluroethylene membrane which is not absorbed and 
does  not react anything to the peritoneal cavity 
Ø Advantage  of its usage in the pericardium 
Ø More effective than intercede in its advantage  of increased vascularity 
and decrease in adhesion area  
Ø It can be easily placed in a peritoneal defect. 
OXIPLAT 
Ø It contains polyethylnee oxide with a high molecular weight along 
with carboxymethylcellulose. 
Ø It has high tissue adherence which is much more biocompatible 
Ø The main advantage is that it can be used laprascopically also. 
Ø It becomes gelatinous and gets removed by phagocytes  
Ø Its advantage over intercede is that the presence of any blood at the 
membrane interface does not decrease its efficacy does not increase 
the formation of intra abdominal abcess. 
SURGIWRAP                                                
Ø Its mechanism of action is to separate the tissue in contact during the 
critical time of peritoneal wound healing 
Ø It is made up of polyoctide and is available in different forms and sizes  
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Ø The component is similar to that of lactic acid which presents same as in 
the  human body and also gets converted to the same 
Ø It gets converted into carbon dioxide and water and released from the 
body through lungs  
PRECLIDE 
It is an expanded form of polytetrafluroethyelene membrane which has 
advantage of being inert and non inflammatory. 
SEPRAFILM 
Is a form of hydrophilic gel which is discussed in detail later 
FIBRONOLYTIC AGENTS 
According to the history Hardwell proposed a theory that  normal peritoneum 
has fibrin decreasing activity further leading to decreased adhesion formation 
recombinant tissue plasminogen activator converts plasminogen into plasmin 
which further causes degradation of fibrin due to the liitle known 
pharmacokinetics of the use of the rt PA its use in adhesion prevention is still 
under study  
FIBRIN GLUE 
Ø its use has been demonstrated in various animal models 
Ø its component is mainly human fibrinogen which is  extracted from 
cryoprecipitate,thrombin,aporetonin,factorXIII 
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Ø Mainly used as bio reactant in cardiac emergencies and extends its 
uses in splenic and liver trauma 
COSEAL 
It is used as the a sealer in the reconstruction of the vascular structures it has 
two polyethyelene glycol which when brought together forms gel mixed with 
water which attaches to no tissue more advantageous  than fibrin glue 
ANTIIFLAMMATORY AGENTS 
Steroid and non steroidal anti inflammatory drugs are used to decrease any 
inflammatory response during the formation of adhesion . 
When mixed with other medication has increased the chance of infection . 
The main disadvantage is that as it is systemically administered it cannot act in 
sites where there  is no blood supply and adhesions are more prone to form in 
those sites certain drugs like campothecin and sodium chromoglycate are under 
study for the use of anti adhesive materials 
 
 
LAPAROSCOPIC ADHESIOLYSIS: 
For gaining access into the  abdominal cavity 3 to 4 puncture wounds are 
needed of the which the main puncture is made infra umblically which is the 
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main telesccopic port along which 2to3 working ports are required.These 
working ports are laterally above 2cm below the level of the  iliac crest the 
success rate of incision depends on making adequate skin incision ,the working 
condition of the trocar and also the depth and force of insertion .Small diameter 
(<3mm) laprascopy can also be used as an alternative than regular laproscopy If 
the patient is of increased risk of adhesion ,on entering the abdominal cavity , 
the adherent bowel or omentum has to be exposed first . If the adhesions are 
crowded and makes it difficult for working parts to enter the free space is  first 
identified and marked with a 21 guage spine needle which makes way for a 
clear entry . 
Once the trocar are placed inside the grasper forced inside through the lateral  
part  is used to hold the adhesion ,traction in order  to identify the avascular 
planes .The other lateral trocar is used as the scissors . adhesions are usually cut 
closer and removed if possible. Adhesion which have vascular component are  
cauterised first using electrocautery .First to be encountered are the adhesions in 
the intestine followed by ovary and tubes thus allowing exposure to surrounding 
pelvic structures .freed intestine are moved in the cephalad direction . ovarian 
adhesions are freed from tubes ,Pelvic side walls and uterus. Hemostasis is 
secured with bipolar . Other devices used are co2 laser, superlaser  40 w laser or 
fibre laser 20w. 
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Complications  
Approximately 6% of cases complicate and most frequently affected organ in 
the bowel. 
Gastrointestinal injuries occurs mainly due to  
Ø Insufficient pneumoperitoneum 
Ø Uncontrolled entry of instruments 
Ø No proper decompression of bowel 
Rectosigmoid injury is inadveredent in the presence of endometriosis or when 
there is obliteration of cul de sac,adhesion between the rectum and posterior 
aspect of cervix can cause laceration into the rectum during blunt dissection in 
this situation sharp scissors is used .a probe can be placed to facilitate the 
identification of vagina and rectum when the cul de sac is opened .dissection 
should always be lateral to the uterosacral ligaments as the anatomy is less 
disturbed in that portion. 
Electrical injuries to the bowel are usually not found intra operatively.If found 
has to be dealt as conservative line of management  
The most common organ injured during laparascopy is the small bowel. It is 
discovered by the leakage of contents from the small bowel 
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SEPRAFILM 
Sepra film is a biodegradable membrane which acts as mechanical membrane 
applied to tissue prone to adhesion just before surgical procedure  
It was indicated to reduce the extent and severity of adhesions in patient prone 
to develop adhesion in abdominopelvic surgeries 
MECHANISM OF ACTION  
v It converts into gel on placing between tissues under handling and 
acts as physical barrier just preventing adhesion 
v It is composed of 2 anion polysaccharides hyaluronic acid and 
carboxymethylcellulose 
v It has reduced water solubility and increased residence then other 
unmodified polymers adding to its efficacy 
v FDA has approved this film since 1996 
PRECAUTIONS 
v Sepra film is not placed in sites of intestinal anastomosis as some 
results show leak in the anastomosis and even produce peritonitis 
v Its safety has not been evaluated in frank sepsis,malignancy and 
pregnancy 
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CLINICAL STUDIES: 
SEPRAFILM and SMALL BOWEL OBSTRUCTION: 
• In  2 studies involving small bowel obstruction with enterolysis and 
transabdominal aortic aneurysm there was significant decrease in the 
early postoperative small bowel obstruction 
• In a retrospective study involving uterine tumours who underwent 
laparotomy it was found to have no significant difference in the number 
of patients who developed small bowel obstruction in both study and 
control group 
SEPRAFILM in LOOPILEOSTOMY 
     In a randomised prospective study,its application around loop ileostomy was 
found to decrease adhesions and facilitate easy  and early closure around 4 
weeks. 
SEPRAFILM IN INFECTIONS 
   A randomised control study showed that the use of seprafilm in peritonitis 
decreased the severity of adhesions but not its incidence. 
  No significant difference in formation of small bowel obstruction in study and 
control groups. 
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SEPRAFILM IN MALIGNANCY 
In a study in patients undergoing cytoreductive surgeries seprafilm placed in the 
pelvic cavity revealed significant reduction in adhesion as referring to control 
groups 
Tan et al suggested a study in women undergoing surgeries involving 
gynaecological malignancies as there were reports suggesting hyaluronan which 
may promote tumour growth. 
It was found that there was no significant difference in the overall survival rate 
and disease free interval. 
SEPRAFILM IN PAEDIATRICS 
 A case series and randomised study were done showing reduction in the 
severity of adhesion and incidence under the midline scar in 9 paediatric 
patients. 
OBSTETRICS 
CAESARIAN SECTION 
There was no decrease in operative time and blood loss in patients who 
underwent previous caesarean section than those who did not. 
A shorter operating time interval was noted from the start of the procedure to 
the time of delivery of the baby. 
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GYNAECOLOGICAL SURGERY 
 In patients who underwent gynaecological surgeries  especially myomectomies 
it has lowest incidence of uterine adhesions compared to all other mechanical 
barrier. 
ADVERSE EFFECTS 
Other than the previously mentioned complications of anastamotic leak, 
peritonitis and abcess, Few minor complications include foreign body 
granuloma, fever and a mild increase in intraabdominal fluid collection. 
COST EFFECTIVENESS 
A study conducted by Bristow  and colleages in women undergoing surgery for 
cervical cancer proved the usage of “seprafilm  is cost effective to perspective 
of society as a whole”.  
Seprafilm Application Technique 
A variety of application techniques may help with successful Seprafilm 
placement, as follows. 
• Seprafilm may be cut, shaped, and handled in various ways 
• Keep retractor in place 
• Create good skin retraction by pulling up and out with retractor 
• The membrane should be handled gently with dry instruments and/or 
gloves 
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Abdominal Seprafilm Application Technique 
 
 
 
Cut full sheet in half. Slightly curve edges upward into taco shape. Pull back 
bottom piece 1-2 cm to expose leading edge of taco. 
 
Guide through incision and touch leading edge on manipulated tissue. While 
gently pressing the membrane down with a dry glove or sponge stick, withdraw 
the bottom holder and then top holder.* 
 
 
 
Remove one layer of the holder. Slide the holder back 1-2 cm to expose a 
leading edge. Curve edges to form a cigar shape with the holder in place. 
 
Guide through incision and touch leading edge on manipulated tissue. Release 
and allow the membrane to unroll. While gently pressing the membrane down 
with a dry glove or sponge stick, withdraw the holder.* 
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Remove top layer of holder. Slide the holder back 1-2 cm to expose a leading 
edge. Slightly curve edges upward. 
 
Guide through incision. While gently pressing the membrane down and forward 
with a sponge stick, withdraw the bottom layer of the holder.* 
 
 
 
 
 
 
Slide holder back 1-2 cm to expose a leading edge. Slightly curve edges 
upward. 
 
Using a dry glove, guide Seprafilm through incision. While gently pressing 
membrane down, remove bottom holder and then top holder. Repeat to form a 
flower shape. 
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Abdominal Seprafilm Application Sites 
It serves as a temporary bioresorbable barrier separating apposing tissue 
surfaces and can be placed between the abdominal wall and the underlying 
viscera, including the: 
• Omentum 
• Small bowel 
• Bladder 
• Stomach 
Seprafilm Adhesion Barrier should not be wrapped directly around a fresh 
anastomotic suture or staple line. 
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OBSERVATION AND RESULTS 
STUDY DESIGN: 
A prospective study with a sample size of 60 patients was conducted at 
Department of General surgery, Madurai Medical College, Madurai. 30 patients 
under the study group under the inclusion criteria were subjected to the  
placement of seprafilm and were monitored for the presence of any 
postoperative complications and observed for the formation of adhesions in the 
20th postoperative day.30 control who have undergone abdominopelvic 
surgeries under the same inclusion criteria are observed for the presence of 
adhesions in the 20th postoperative day. Results were discussed at the end of the 
study. 
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DISTRIBUTION OF CASES ACCORDING TO AGE 
 
AGE	 CASES	 CONTROL	
<	40	 10	 11	
41--50	 9	 9	
51--60	 10	 10	
TOTAL	 29	 30	
Mean	 46.2	 46.367	
SD	 14.423	 13.187	
P'Value	 0.963	 Not	sig	
 
 
Patients were randomly designated to the study and control groups.THE MEAN 
AGE of both the control and study was found to be 46.36 and 46.2 
respectively.The p value is 0.963 thus making it not significant. 
 
Thus the distribution of cases according to age does not influence the placement 
of seprafilm or the formation of adhesions. 
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DISTRIBUTION OF CASES ACCORDING TO SEX: 
 
 
 
 
In the study conducted 11 patients in the study group and 12 cases in control 
group were males and 19 cases in the study group and 18 cases in the control 
group were females. The p value of sex distribution is 0.946. 
 
Thus the placement of seprafilm and its outcome is influenced by sex 
distribution as the p value is not significant. 
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PREVIOUS	SURGERY	 CASES	 CONTROL	
YES	 17	 15	
NO	 13	 15	
TOTAL	 30	 30	
 
Previous history of surgery is an important factor in formation of adhesions as 
surgery done early  allows the contact of peritoneum to the previous scar tissue 
leading to fibrin formation. Out the 30 cases in study group 17 cases had history 
of surgery and 15 cases in control groups. 
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A wide variety of cases were subjected to the placement of seprafilm meeting 
the exclusion criteria of no history of patients with intestinal anastamosis or in 
procedures requiring intestinal anastamosis along with immune compromised 
patients. 
 
 
 
 
   
   
PREOP	DIAGNOSIS	 CASES	 CONTROL	
CHOLELITHIASIS	 3	 2	
EPIGASTRIC	HERNIA	 1	 2	
FATTY	HERNIA	OF	LINEA	ALBA	 0	 1	
FISTULA	POST	HYDATID	EXCISION	 0	 1	
INCISIONAL	HERNIA		 12	 11	
IRREDUCIBLE	EPIGASTRIC	HERNIA		 1	 0	
IRREDUCIBLE	UMBILICAL	HERNIA	 0	 1	
OBSTRUCTED	INCISIONALHERNIA	 0	 1	
PARA	UMBILICAL	HERNIA	 1	 0	
POST	APPENDICECTOMY	FISTULA	 0	 1	
PORT	SITE	INCISIONAL	HERNIA	 1	 0	
RECURRENT	INCISIONAL	HERNIA	 1	 0	
SUBACUTE	INTESTIANL	OBSTRUCTION	 2	 0	
UMBILICAL	HERNIA	 7	 10	
VENTRAL	HERNIA	 1	 0	
TOTAL	 30	 30	
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PROCEDURE		 CASES	 CONTROL	
ADHESIOLYSIS	 2	 0	
FISTULOUS	TRACT	EXCISION	 0	 2	
OPEN	CHOLECYSTECTOMY	 2	 2	
OPEN	CHOLECYSTECTOMY	WITH	UMBILICAL	HERNIA	 1	 0	
OPEN	MESH	REPAIR	 25	 26	
TOTAL	 30	 30	
 
Out of the 60 patients under study 25 patients in the study group and 26 patients 
in the control group underwent open mesh repair. 
 
2 of the cases in the study group underwent adhesiolysis with previous history 
of surgey.The placement of seprafilm in these patients showed no evidence of 
adhesions in the 20th day ct in the subsequent surgey performed.   
 
 
 
 82 
 
 
0 
5 
10 
15 
20 
25 
30 
ADHESIOLYSIS FISTULOUS TRACT 
EXCISION 
OPEN 
CHOLECYSTECTOMY 
OPEN 
CHOLECYSTECTOMY 
WITH UMBILICAL 
HERNIA 
OPEN MESH REPAIR 
2 
0 
2 1 
25 
0 
2 2 
0 
26 
PROCEDURE 
CASES 
CONTROL 
 83 
 
POST	OP	COMPLICATIONS	 CASES	 CONTROL	
NIL	 26	 15	
FEVER	 3	 9	
PAIN	 0	 4	
WOUND	INFECTION	 1	 2	
TOTAL	 30	 30	
P'Value	
0.048	 Significant	
 
 
 
In this study immediate post operative fever occurred in 3 patients in the study 
group and 9 cases n in the control group.4 patients in the control group 
experienced postoperative pain in 3rd to 7th day while nil pain in patients using 
seprafilm. 
This pain may be contributed due to the presence of adhesions in the post 
operative period in the control group. The pvalue is 0.048 which is significant 
indicates pain is more common in postoperative patients with adhesions. 
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CT(20th	DAY)	 CASES	 CONTROL	
EXTENSIVE	ADHESIONS	 0	 1	
MINIMAL	ADHESIONS	 4	 15	
NO	ADHESIONS	 26	 14	
TOTAL	 30	 30	
P'Value	
0.037	 Significant	
 
In this study 30 cases in the study group were subjected to the placement of 
seprafilm.Out of the 30 patients  in the study group only 4 patients developed 
minimal adhesions in the 20th post operative day CT while compared to 16 
patients out of the 30 in the control group. 
 
The p value is 0.037 which is significant.Thus this study proves the 
effectiveness of seprafilm as a adhesion barrier in abdominopelvic surgeries.  
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DISCUSSION 
Results of the study has been discussed in detailed in the following section. 
AGE DISTRIBUTION AND ADHESION 
In two large surveys conducted postsurgical adhesion formation did not show 
any dependence to age. There is no prospective evaluation of the effect of age 
witn adhesion. 
Weibel and Majos reported increased frequency of spontaneous adhesions after 
the age of 60. 
In our study distribution of age is categorised into age<40,41-50 and 51-60.The 
Mean age in cases is 46.2 and in control group was 46.36.The p value is 0.963 
which is not significant.Thus in our study age does not contribute in formation 
of adhesions for the placement of Seprafilm. 
 
SEX DISTRIBUTION AND ADHESION 
There is no sex bias in the development of postoperative adhesions. Weibel and 
Mojo reported very slight increase in frequency in formation of adhesions in 
male patients. Raf in his study reported the incidence of adhesions to be 48% in 
males and 52%in female patients. 
In this study male:female ratio in the study group is 11:19 and in the control 
group is 12:18.The p value is 0.946 which is not significant.Thus male and 
female have equal preponderance in formation of postoperative adhesions thus 
favouring application of seprafilm in both sexes. 
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PREVIOUS HISTORY OF LAPROTOMY 
The omentum is the primary organ to be involved in adhesion 
formation.According to Weibel and Majno 100%of the 128 patients under 
spontaneous adhesion revealed involment of omentum. 
Previous history of surgery which involves peritoneal suturing does not alter the 
formation of adhesion in allowing the peritoneum to heal or reapproximation 
with sutures.There is no difference in adhesiom relating to previous laparotomy. 
  
In this study 17 cases in the study group and 15 cases in the control group had 
previous history of surgery.There is no specific difference in the changes in 
adhesions in previous history of laparotomy done. 
 
INCISION IN PROCEDURE PERFORMED 
Brill et al correlated location and frequency of skin incision in the formation of 
adhesion. Adhesion to bowel and omentum were found in 27% of patients in the 
pfannensteil group,in 58%in midline incision above the umbilicus,and in 67% 
of patients in incisions below the umbilicus. 
In our study except for 4 patients who underwent open cholecystectomy with 
roof top incisions the remaining patients had conventional midline scars. So the 
incidence of adhesion due incidence in this study is not significant. 
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POSTOPERATIVE COMPLICATIONS. 
 
Minor complictaions noted in studies after placement of seprafilm include 
anastamotic leak,peritonitis,abdominal abcess and very few cases reporting 
foreign body reaction.Patients who need procedures involving intestinal 
anastomosis are excluded from the group under study. 
No such complications occurred  in patients under study group. 
 
3 patients developed postoperative fever which settled before 3rd postoperative 
day.1 case developed wound infection which was managed conservatively. 
In the control group 9 cases developed fever which settled within 3rd post 
operative day.4 patients developed postoperative pain till 7th day which may 
attribute to formation of adhesions as all developed adhesions in the 20th day 
CT. 
 
EFFECTIVENESS OF SEPRAFILM 
30 cases in study group were subjected to the placement of seprafilm after 
obtaining prior written informed consent explaining the possible complications 
in detail. 
Out of 30 patients only 4 patients developed mimimal adhesions as compared to 
16 patients who developed adhesions in the control group as evident by the 20th 
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day CT. The pvalue 0.037 which is significant thus proving the effectiveness of 
seprafilm as an adhesion barrier in abdominopelvic surgery. 
 
CONCLUSION 
Formation of adhesions has attributed to the morbidity of patients in terms of 
hospital and frequent readmissions along with development of complications 
like bowel obstruction,chronic pain and certain times vascular compromise.This 
study conducted in the DEPARTMENT OF GENERAL SURGERY in Govt 
Rajaji Hospital Madurai  explains the usefulness and effectiveness of separfilm 
as an adhesive barrier in abdominopelvic surgery. 
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PROFORMA 
  
Date:         STUDY/ CONTROL 
Name:                                            Age :                                Sex:          
IP no:                           Height:                            Weight: 
Pre-operative diagnosis: 
 
DETAILS OF SURGERY 
Date of surgery: 
Procedure done:      Elective/ Emergency 
Duration of Surgery(hours): 
Intra operative findings: 
 
 
Seprafilm  used  /  not used 
If not used, any contra-indications: 
 
POST OPERATIVE COURSE 
Complications if any (immediate Post op period): 
 
CT findings (20th POD) 
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S.No
. NAME AGE SEX IP	NO
PREVIOUS	
SURGERY PREOP	DIAGNOSIS PROCEDURE	
SEPRAFILM	
USED POST	OP	COMPLICATIONS CT(20th	DAY)
1 PALANIKUMAR		 26 M 1141659 YES INCISIONAL	HERNIA	 OPEN	MESH	REPAIR USED NIL
MINIMAL	
ADHESIONS
2 MAHESHWARI 80 F 1136972 YES
IRREDUCIBLE	EPIGASTRIC	
HERNIA	 OPEN	MESH	REPAIR USED FEVER NO	ADHESIONS
3 BACKIYAM 55 F 1133196 YES
RECURRENT	INCISIONAL	
HERNIA OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
4 SARASWATHI 48 F 1140443 YES INCISIONAL	HERNIA	 OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
5 SENTHIL	KUMAR 27 M 1131752 YES INCISIONAL	HERNIA	 OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
6 KANNAN 32 M 1126496 NO EPIGASTRIC	HERNIA OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
7 MAHALINGAM 34 M 1127502 YES INCISIONAL	HERNIA	 OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
8 ALAGU 46 F 1124743 YES INCISIONAL	HERNIA	 OPEN	MESH	REPAIR USED WOUND	INFECTION NO	ADHESIONS
9 MURUGAN 46 M 1123116 YES
PORT	SITE	INCISIONAL	
HERNIA OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
10 PETCHIAMMAL 30 F 1123082 YES INCISIONAL	HERNIA	 OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
11 THANGAM 45 F 1123070 YES INCISIONAL	HERNIA	 OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
12 PANDI 49 M 1120260 NO UMBILICAL	HERNIA OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
13
LAKSHMIAMMA
L 70 F 1117270 YES INCISIONAL	HERNIA	 OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
14 CHANDRA 46 F 1117166 NO VENTRAL	HERNIA OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
15 BUVANESHWARI 25 F 1117220 NO UMBILICAL	HERNIA OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
16 KARUPPASAMY 25 M 1114880 YES INCISIONAL	HERNIA	 OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
17 SYED	SADANA 51 F 1112912 YES
	INCISIONAL	HERNIA	
WITH	UMBILICAL	HERNA OPEN	MESH	REPAIR USED FEVER
MINIMAL	
ADHESIONS
18 PAPPA 60 F 1115729 NO UMBILICAL	HERNIA OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
19 KURUVAMMAL 60 F 1112950 NO UMBILICAL	HERNIA OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
20 VIRUMANDI 42 M 1110017 YES INCISIONAL	HERNIA	 OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
21 SELVI 36 F 1107041 YES INCISIONAL	HERNIA	 OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
22 PAPPA 58 F 1114389 NO UMBILICAL	HERNIA OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
23 CHANDRASEKAR 58 M 1112898 NO CHOLELITHIASIS
OPEN	
CHOLECYSTECTOMY USED NIL NO	ADHESIONS
24 PREMA	 65 F 1107082 NO UMBILICAL	HERNIA OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
25 MUTHUPETCHI 50 F 1107119 YES
SUBACUTE	INTESTIANL	
OBSTRUCTION ADHESIOLYSIS USED NIL NO	ADHESIONS
26
SELVAJEYAKUM
AR 35 F 42746 NO CHOLELITHIASIS
OPEN	
CHOLECYSTECTOMY USED NIL NO	ADHESIONS
27 PANDI 30 M 1053626 YES
SUBACUTE	INTESTIANL	
OBSTRUCTION ADHESIOLYSIS USED FEVER
MINIMAL	
ADHESIONS
28 JEYALAKSHMI 42 F 105663 NO
CHOLELITHIASIS	WITH	
PARAUMBILICAL	HERNIA
OPEN	
CHOLECYSTECTOMY	
WITH	UMBILICAL	
HERNIA USED NIL
MINIMAL	
ADHESIONS
29 BOSE 50 M 1065174 NO UMBILICAL	HERNIA OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
30 LAKSHMI	 65 F 1062413 NO PARA	UMBILICAL	HERNIA OPEN	MESH	REPAIR USED NIL NO	ADHESIONS
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NAME AGE SEX IP	NO PREVIOUS	
SURGERY
PREOP	
DIAGNOSIS
PROCEDURE	 SEPRAFILM	
USED
POST	OP	
COMPLICAT
IONS
CT(20th	DAY)
1 CHINNAIYAN 42 M 1105728 YES
INCISIONAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED NIL
MINIMAL	
ADHESIONS
2 PANDIAMMAL 49 F 1105816 YES
INCISIONAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED NIL
MINIMAL	
ADHESIONS
3 AMSAVALLI 56 M 1105768 YES
INCISIONAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED FEVER NO	ADHESIONS
4 KALIMUTHU 50 M 1105796 YES
OBSTRUCTED	
INCISIONALHERNI
A
OPEN	MESH	
REPAIR NOT	USED PAIN
MINIMAL	
ADHESIONS
5 VISALAKSHI 33 F 1104310 NO
UMBILICAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED FEVER
MINIMAL	
ADHESIONS
6
ARPUDHAMA
RY 45 F 48996 NO
IRREDUCIBLE	
UMBILICAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED FEVER NO	ADHESIONS
7 JESINDHA 60 F 10944108 YES
FISTULA	POST	
HYDATID	
EXCISION
FISTULOUS	
TRACT	
EXCISION NOT	USED PAIN
MINIMAL	
ADHESIONS
8 PANDIAMMAL 60 F 29956 YES CHOLELITHIASIS
OPEN	
CHOLECYSTECT
OMY NOT	USED PAIN
EXTENSIVE	
ADHESIONS
9
PETCHIAMMA
L 37 F 1090184 YES
INCISIONAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED NIL NO	ADHESIONS
10
JOHN	
KENNEDY	 50 M 47392 NO
UMBILICAL	
HERNIA
	OPEN	MESH	
REPAIR NOT	USED NIL NO	ADHESIONS
11 SASIKUMAR 35 M 1085683 NO
UMBILICAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED
WOUND	
INFECTION
MINIMAL	
ADHESIONS
12 SHANTHI 27 F 1087215 NO
UMBILICAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED FEVER NO	ADHESIONS
13 POOMAYIL 70 F 1080367 YES
INCISIONAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED NIL
MINIMAL	
ADHESIONS
14 MURUGESAN 53 M 1079017 NO
UMBILICAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED FEVER NO	ADHESIONS
15
VELLAIAMMA
L 32 F 10735510 YES
INCISIONAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED FEVER
MINIMAL	
ADHESIONS
16
VEERABATHR
AN 47 M 1079214 NO
FATTY	HERNIA	OF	
LINEA	ALBA
OPEN	MESH	
REPAIR NOT	USED NIL NO	ADHESIONS
17 IRULAYEE 40 F 1070607 NO
EPIGASTRIC	
HERNIA
OPEN	MESH	
REPAIR NOT	USED NIL NO	ADHESIONS
18
AAVUDAIAM
MAL 65 F 1069520 YES
INCISIONAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED NIL
MINIMAL	
ADHESIONS
19
SABARIAMMA
L 64 F 1066287 NO
EPIGASTRIC	
HERNIA
OPEN	MESH	
REPAIR NOT	USED FEVER
MINIMAL	
ADHESIONS
20 MEENAKSHI 53 F 1067233 YES
INCISIONAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED PAIN
MINIMAL	
ADHESIONS
21 AROKIYAM 65 M 1065183 NO
UMBILICAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED NIL NO	ADHESIONS
22
RAMALAKSHM
I 50 F 1141599 NO
UMBILICAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED NIL NO	ADHESIONS
23 SIKKANDER 30 M 1127623 YES
POST	
APPENDICECTOM
Y	FISTULA
FISTULOUS	
TRACT	
EXCISION NOT	USED
WOUND	
INFECTION
MINIMAL	
ADHESIONS
24 KAVITHA 31 F 1051833 NO CHOLELITHIASIS
OPEN	
CHOLECYSTECT
OMY NOT	USED NIL
MINIMAL	
ADHESIONS
25
SURESH	
KUMAR 39 M 1051231 NO
UMBILICAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED FEVER NO	ADHESIONS
26 CHANDRAN 45 M 1143567 YES
INCISIONAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED NIL
MINIMAL	
ADHESIONS
27
BALAKRISHNA
N 46 M 1142532 YES
INCISIONAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED NIL NO	ADHESIONS
28 PHILOMINA 66 F 1142569 YES
INCISIONAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED FEVER
MINIMAL	
ADHESIONS
29 NAGAJOTHI 22 F 1143763 NO
UMBILICAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED NIL NO	ADHESIONS
30
DHANALAKSH
MI 29 F 1143763 NO
UMBILICAL	
HERNIA
OPEN	MESH	
REPAIR NOT	USED NIL NO	ADHESIONS
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